Oxford University Innovation reported a record $698m of funding for its portfolio businesses in a year which brought its total number of spinouts to more than 170.

Wren Therapeutics is commercialising Cambridge and Lund research into therapies for protein misfolding diseases, which include Alzheimer's and motor neurone disease.

Santander and Barclays have co-led MarketInvoice’s $33.6m series B round, which the fintech developer raised in addition to a $38.8m in debt financing.

SAP will commit 40% of the investable capital in its SAP.io Fund to support startups led by women and minorities, with a goal of backing at least 200 such companies within five years.

The IP Group-owned fund management unit closed three university funds targeting Cambridge, Oxford and Bristol-linked companies last year.

The LivaNova-backed mitral valve replacement system developer has collected $36.3m in a round that increased its funding to almost $57m altogether.

SetSquared affiliates together raised 34% more than the equivalent generated in 2017 in what was hailed as a stellar year for the program.

Boeing HorizonX Ventures has led a series A round for the satellite terminal developer, which plans to work with the corporate's other portfolio companies in developing its technology.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Machine tools supplier Trumpf has put funding behind Eyewear Tech to commercialise an eye tracking platform based on Idiap Research Institute and EPFL technology.